131 related articles for article (PubMed ID: 10836282)
1. Effective open-label treatment of tourette's disorder with olanzapine.
Stamenkovic M; Schindler SD; Aschauer HN; De Zwaan M; Willinger U; Resinger E; Kasper S
Int Clin Psychopharmacol; 2000 Jan; 15(1):23-8. PubMed ID: 10836282
[TBL] [Abstract][Full Text] [Related]
2. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder.
Budman CL; Gayer A; Lesser M; Shi Q; Bruun RD
J Clin Psychiatry; 2001 Apr; 62(4):290-4. PubMed ID: 11379844
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study.
Stephens RJ; Bassel C; Sandor P
J Child Adolesc Psychopharmacol; 2004; 14(2):255-66. PubMed ID: 15319022
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
Cui YH; Zheng Y; Yang YP; Liu J; Li J
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP
J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
Lyon GJ; Samar S; Jummani R; Hirsch S; Spirgel A; Goldman R; Coffey BJ
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):623-33. PubMed ID: 20035580
[TBL] [Abstract][Full Text] [Related]
7. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine in Tourette's disorder.
Bengi Semerci Z
J Am Acad Child Adolesc Psychiatry; 2000 Feb; 39(2):140. PubMed ID: 10673820
[No Abstract] [Full Text] [Related]
9. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
[TBL] [Abstract][Full Text] [Related]
10. Open-label olanzapine treatment in five preadolescent children.
Krishnamoorthy J; King BH
J Child Adolesc Psychopharmacol; 1998; 8(2):107-13. PubMed ID: 9730076
[TBL] [Abstract][Full Text] [Related]
11. [Olanzapine in Tourette's syndrome: a report of three cases].
Lucas Taracena MT; Montañés Rada F
Actas Esp Psiquiatr; 2002; 30(2):129-32. PubMed ID: 12028946
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of tics in Tourette syndrome with atypical antipsychotic drugs].
Sindø I; Jørgensen JI
Ugeskr Laeger; 2002 Aug; 164(32):3755-9. PubMed ID: 12362607
[TBL] [Abstract][Full Text] [Related]
13. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.
Frazier JA; Biederman J; Tohen M; Feldman PD; Jacobs TG; Toma V; Rater MA; Tarazi RA; Kim GS; Garfield SB; Sohma M; Gonzalez-Heydrich J; Risser RC; Nowlin ZM
J Child Adolesc Psychopharmacol; 2001; 11(3):239-50. PubMed ID: 11642474
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine in Tourette's disorder.
Karam-Hage M; Ghaziuddin N
J Am Acad Child Adolesc Psychiatry; 2000 Feb; 39(2):139. PubMed ID: 10673819
[No Abstract] [Full Text] [Related]
15. Switching outpatients with schizophrenia and related disorders on long-acting injectable antipsychotics to olanzapine: an open-label naturalistic pilot study.
Labelle A; Bourget D; Boulay LJ; Ellis J; Tessier P
J Clin Psychopharmacol; 2002 Dec; 22(6):545-53. PubMed ID: 12454553
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine in treatment-resistant bipolar disorder.
McElroy SL; Frye M; Denicoff K; Altshuler L; Nolen W; Kupka R; Suppes T; Keck PE; Leverich GS; Kmetz GF; Post RM
J Affect Disord; 1998 May; 49(2):119-22. PubMed ID: 9609675
[TBL] [Abstract][Full Text] [Related]
17. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.
Silver AA; Shytle RD; Philipp MK; Wilkinson BJ; McConville B; Sanberg PR
J Clin Psychiatry; 2001 Sep; 62(9):707-14. PubMed ID: 11681767
[TBL] [Abstract][Full Text] [Related]
18. A prospective, open-label trial of olanzapine in adolescents with schizophrenia.
Findling RL; McNamara NK; Youngstrom EA; Branicky LA; Demeter CA; Schulz SC
J Am Acad Child Adolesc Psychiatry; 2003 Feb; 42(2):170-5. PubMed ID: 12544176
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of olanzapine in social anxiety disorder: a pilot study.
Barnett SD; Kramer ML; Casat CD; Connor KM; Davidson JR
J Psychopharmacol; 2002 Dec; 16(4):365-8. PubMed ID: 12503837
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.
Weiden PJ; Simpson GM; Potkin SG; O'Sullivan RL
J Clin Psychiatry; 2003 May; 64(5):580-8. PubMed ID: 12755663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
